Covid-19 roundup: FDA to give OK for mix-and-match booster shots — report; WHO group leads campaign to acquire antiviral drugs for $10
The mix-and-match school of thought is picking up a victory as the FDA reportedly plans to allow Americans to receive a different Covid-19 booster than the one originally received in an effort to provide flexibility to doctors and recipients alike.
By the end of this week, tens of millions of Americans could be eligible for a booster shot, the New York Times reports, as regulators are expected to announce authorizations for the Moderna and J&J shots.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
